Speaker illustration

Mr Peter Bronnum Nielsen

Aalborg University Hospital, Aalborg (Denmark)

Member of:

European Society of Cardiology

Comparative effectiveness and safety of edoxaban vs warfarin in patients with atrial fibrillation: a nationwide cohort study

Event: ESC Congress 2021 - The Digital Experience

Topic: Epidemiology, Prognosis, Outcome

Session: Atrial fibrillation: risks and management

Thumbnail

Risk of cerebrovascular events in intracerebral haemorrhage survivors with atrial fibrillation: The Danish Stroke Registry

Event: ESC Congress 2021 - The Digital Experience

Topic: Stroke in Atrial Fibrillation

Session: Congress committee e-posters choice in arrhythmias and device therapy

Thumbnail

Risk of ischemic stroke and recurrent ICH in patients with atrial fibrillation presenting with incident ICH: an analysis from the Danish Stroke Registry

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Stroke in Atrial Fibrillation

Session: Atrial Fibrillation ePosters

Thumbnail

Prevention of stroke in intracerebral haemorrhage survivors with atrial fibrillation (PRESTIGE-AF): a retrospective cohort study

Event: ESC CONGRESS 2019

Topic: Cardiovascular Epidemiology

Session: Cardiovascular epidemiology and trials

Thumbnail

Female sex is a risk modifier - not a risk factor - for stroke risk assessment in atrial fibrillation: Using a CHA2DS2-VA score rather than CHA2DS2-VASc

Event: ESC CONGRESS 2017

Topic: Atrial fibrillation (AF)

Session: Stroke risk prediction in atrial fibrillation

Thumbnail

Patient with a CHA2DS2VASc score of 1: what to do?

Event: ESC CONGRESS 2017

Topic: Atrial fibrillation (AF)

Session: Stroke prevention in atrial fibrillation: the known knowns and the known unknowns

Thumbnail

Predictive value of the HAS-BLED, ATRIA, and ORBIT bleeding risk classification in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants (NOACs)

Event: ESC CONGRESS 2017

Topic: Atrial fibrillation (AF)

Session: Bleeding and LAA occlusion

Thumbnail

Outcomes associated with oral anticoagulant treatment post haemorrhagic stroke or traumatic intracranial bleeding: a nationwide cohort study on atrial fibrillation patients

Event: ESC CONGRESS 2016

Topic: Atrial fibrillation (AF)

Session: Registries miscellaneous

Thumbnail

When should we start thromboprophylaxis? The stroke risk threshold discrepancy between European and U.S. guidelines for atrial fibrillation

Event: ESC CONGRESS 2016

Topic: Atrial fibrillation (AF)

Session: New trends in antithrombotic therapy for atrial fibrillation

Thumbnail

This platform is supported by

logo Novo Nordisk